Acelyrin Inc.

2.77
0.26 (10.36%)
At close: Apr 02, 2025, 3:59 PM
2.57
-7.05%
After-hours: Apr 02, 2025, 07:20 PM EDT

Acelyrin Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue n/a n/a n/a n/a
Cost of Revenue n/a 115K n/a n/a
Gross Profit n/a -115K n/a n/a
Operating Income -316.26M -422.06M -254.68M -41.79M
Interest Income 31.21M 30.55M 4.17M n/a
Pretax Income -248.23M -381.64M -250.46M -41.84M
Net Income -248.23M -381.64M -250.46M -41.84M
Selling & General & Admin 66.81M 66.18M 24.05M 3.56M
Research & Development 238.06M 355.89M 230.63M 38.23M
Other Expenses 11.39M n/a -132K -45K
Operating Expenses 316.26M 422.06M 254.68M 41.79M
Interest Expense n/a n/a n/a n/a
Selling & Marketing Expenses n/a n/a n/a n/a
Cost & Expenses n/a 422.06M 254.68M 41.79M
Income Tax n/a n/a -4.17M -41.79K
Shares Outstanding (Basic) 99.3M 70.25M 20.44M 20.44M
Shares Outstanding (Diluted) 99.3M 70.25M 20.44M 20.44M
EPS (Basic) -2.5 -5.43 -12.25 -2.05
EPS (Diluted) -2.5 -5.43 -12.25 -2.05
EBITDA -316.26M -381.53M -64.77M -41.84M
EBIT n/a -381.64M -64.77M -41.84M
Depreciation & Amortization n/a 115K 69.18K 41.79K